Oncology Institute Q3 revenue $65M (+24% YoY); cuts FY2022 guidance on slower acquisitions

Oncology Institute, Inc.

2022-Q3 EPS reported -$0.03 revenue$181,059,000

Net loss $2.7M ($0.03 basic loss per share); adjusted EBITDA -$7M vs +$0.1M prior year.
Revenue guidance cut to $245-250M from $270-310M; adjusted EBITDA guidance lowered to -$28M to -$25M.
Completed $110M strategic investment via senior convertible notes from Deerfield on August 9, 2022.
Ended Q3 with 100 clinicians (+27% YoY); expanded to 14 markets with three acquisitions and two de novo clinics.
Workforce reduction and vendor cost-cutting initiated to align cost structure with revenue growth.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Oncology Institute, Inc. reported three months ended September 30, 2022 results: revenue $65 million, net income Net loss of $2.7 million, EPS $(0.03). Guidance raised.

Period: three months ended September 30, 2022
Revenue: $65 million
Net income: Net loss of $2.7 million
EPS: $(0.03)
Guidance: raised
Result: reported results

Exact text from the filing

Reger in newly created Chief Information Officer role and Cristina Green as Vice President of Clinical Research Third Quarter 2022 Financial Highlights • Consolidated revenue of $65 million, an increase of 24.3% from $52 million for the prior year quarter • Gross profit of $13 million, an increase of 13.8% compared to the prior year quarter • Net loss of $2.7

View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-029221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.